Xiaofeng Liang


  Deputy Director General of Chinese Center for Disease Control and Prevention (China CDC).
   
  Dr. Xiaofeng Liang received his medical degree at Shanxi Medical University in 1984 and Master degree of Public Health from College of Public Health of Peking University of Medicine in 1995. From 1996 to 1998, he worked as a visiting scholar at the Department of Psychiatry and Behavioral Sciences, College of Medicine, University of Miami, Florida, USA.
   
  After back China in 1998, he holds Vice-Director of Epidemic Prevention Station of Gansu Province (1999-2000), Vice-Director of Institute of Epidemiology and Microbiology, CAPM (2000-2001), And the Director of Immunization Program (NIP) of China CDC (2001-2011). Since 2011 he became a deputy director of China CDC.
  He was the winner of Wu Jieping-Paul Janson Medicine and Pharmacy award 2013 and rewarded as a middle-aged outstanding contribution expert of Ministry of Health China 2011-2012. He received the special allowance subsided by State Council of China in 2010.
   
  Since 2008, he has been a member of Global Strategy Advisory Group of Experts (SAGE) on Immunization of WHO. He served on the Vice Secretary-general of Chinese Foundation of Hepatitis Prevention (2005). He was the member of Chinese Committee Advisory of Immunization Practice, Chinese Association of Community Health and the Branch of Biological Products, Chinese Association of Prevention Medicine. He was member of National Polio Eradication Certification Committee and Member of National Measles Elimination Verification Committee.
   
  His research in public health led to advances in immunization, and vaccine preventable disease control in China. His main scientific research as the principal investigator on the epidemiology regularity and prevention and control countermeasures of Hepatitis B in Key Programs for Science and Technology Development of China from 2004 to now. Current years, he switched to non-communicable diseases control, nutrition and tobacco control. He is the author of more than 30 articles in national and international journals, such as The Lancet, The New England Journal of Medicine.